-
Study aim
-
The Comparison of Teriadent and Thyme spray in aphthous: a clinical trial
-
Design
-
Clinical trials with a control group, randomized. Patients are randomly divided into two groups using SPSS software.
-
Settings and conduct
-
This study will be performed on all patients referred to the the School of Dentistry of Islamic Azad University in 2019, whose diagnosis of minor oral aphthous in their oral mucosa has been confirmed. Sampling will be done based on inclusion and exclusion criteria and for each treatment group, 23 samples and a total of 46 samples will be considered.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: definitive diagnosis of minor oral aphthous by specialist dentistry, life span is 2 days or less, consent to participate in the study. Exclusion criteria: Pregnancy,
concomitant use of any topical drug for the treatment of aphthous, atypical cases of pests and cases suspected of Behcet's syndrome, inflammatory bowel disease, or history of any type of underlying illness that can predispose a person to aphthous, age under 12 years, patients with diseases that impair wound or systemic healing such as diabetes, kidney disease, anemia, liver disease, use of any effective medications for wound healing, such as corticosteroids, anticoagulants, immunosuppressive drugs, chemotherapy, the use of any type of topical or systemic analgesic, and drug and tobacco use
-
Intervention groups
-
Control group: In this group, the drug treatment will be with triamcinolone (Triadent oral paste belonging to Raha Pharmaceutical Company) will be applied to the wound 4 times a day for 15 minutes. Intervention group: Thyme spray (Zardband company, Iran) will be sprayed in the mouth 4 times a day after each meal and at bedtime.
-
Main outcome variables
-
Clinical parameters include pain intensity and the size of the lesion.